ArticleJornal de pediatria
Characteristics of patients with neonatal intrahepatic cholestasis caused by citrin deficiency in China: long-term follow-up outcomes.
Article in Jornal de pediatria. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCitrin deficiency (CD) is an autosomal recessive disease caused by mutations in the SLC25A13 gene. This study aimed to expand the current body of data on Chinese patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) by analyzing their clinical characteristics, genetic mutation spectrum, and long-term follow-up outcomes.
methodsFrom May 2013 to April 2025, 60 children diagnosed with NICCD were enrolled in this retrospective study. Related data were obtained from medical records.
resultsAmong 60 patients, common presentations included elevated aspartate aminotransferase (100%), infantile cholestasis (95.0%), elevated citrulline (96.7%), hyperlactatemia (93.3%), hypoproteinemia (81.7%), coagulation dysfunction (60.0%), hyperammonemia (48.3%) and chubby face (36.7%). Twenty-eight SLC25A13 variants were detected, with c.852_855delTATG (42.7%), IVS16ins3kb (15.4%) and c.615+5G>A (10.3%) being the most frequent. All patients were fed lactose-free milk powder enriched with medium-chain triglycerides (MCT) after diagnosis or suspected diagnosis. Ten patients were lost to follow-up. Among 50 followed patients, 30 were followed for > 5 years. Twenty-four patients showed typical dietary features. After discharge, 11 had hypoglycemic episodes, 5 had growth retardation, 11 had dyslipidemia and 3 progressed to failure to thrive and dyslipidemia caused by citrin deficiency (FTTDCD). All patients remained in stable condition.
conclusionPatients with neonatal intrahepatic cholestasis caused by citrin deficiency present with a variety of clinical manifestations. c.852_855delTATG, IVS16ins3kb and c.615+5G>A are the mutation hotspots of the SLC25A13 gene in Zhejiang, China. Early intervention leads to a good prognosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.